Arcoxia licensed for pain following dental surgery

Arcoxia (etoricoxib) has been approved for the short-term treatment of moderate pain associated with dental surgery.

As well as it's use following dental surgery, etoricoxib is also licensed for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis | SCIENCE PHOTO LIBRARY
As well as it's use following dental surgery, etoricoxib is also licensed for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis | SCIENCE PHOTO LIBRARY

The recommended dose of etoricoxib is 90mg once daily for a maximum of 3 days. Additional postoperative analgesia can be prescribed if required.

No dosage adjustment is necessary for the elderly. However, etoricoxib is contraindicated in patients with creatinine clearance <30ml/min and dose reduction is required for patients with hepatic impairment.

View Arcoxia drug record

Further information: Merck Sharp & Dohme Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from intelog

Excessive steroid dosing highlighted in inflammatory bowel disease

Excessive steroid dosing highlighted in inflammatory bowel disease

Some patients with Crohn's disease or ulcerative colitis...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Femoston 1/10, Flixotide Nebules, Synalar C...

Blood Glucose Testing Strips and Meters

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.

intelog Learning's Espresso CPD helps GPs to top up credits for appraisal

intelog Learning's Espresso CPD helps GPs to top up credits for appraisal

Bite-size Espresso learning can help you top up your...